The Endocrinology Network® Endocrinology clinical resource center is a central hub for all endocrine diseases featured on the site. Designed to offer clinicians the latest across multiple fields of endocrinology, this page hosts content related to diabetes, hormone therapy, women’s health, thyroid disorders, and much more. Check back for news on FDA approvals, the latest studies, conference coverage, case reports, and guideline updates.

Dasiglucagon (Zegalogue) Approved by FDA for Severe Hypoglycemia in Children and Adults

March 22, 2021

Zealand Pharma announced the US FDA approved dasiglucagon (Zegalogue) for treatment of severe hypoglycemia in patients with diabetes aged 6 and older and the injectable will be available as both an auto injector and a prefilled syringe.

Thyroid Combination Therapy Preferred Over Levothyroxine for Some Hypothyroidism Patients

March 21, 2021

A randomized, 3-arm study is giving further insight into the effects of levothyroxine monotherapy compared against a thyroid combination therapy and desiccated thyroid extract for management of hypothyroidism, particularly in patients with Thr92AlaD2 polymorphism.

Many Endocrine Providers, Patients Open to Continuing Telehealth Practices

March 21, 2021

An analysis of patients and providers from endocrine clinics suggests many patients and providers were open to continuing with telehealth practices after the pandemic and many saw little to no limitations with the new practices.